Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole

Caitlin R. Rausch, Adam J. DiPippo, Prithviraj Bose, Dimitrios P. Kontoyiannis

Clinical Infectious Diseases · 2018 · 104 citations · 11 references

DOIFull text

Open access

Concepts

Abstract

We retrospectively assessed breakthrough invasive fungal infections (b-IFIs) in 100 consecutive patients with leukemia receiving single-agent isavuconazole; 13 had documented b-IFIs (candidiasis in 6, mucormycosis in 4). All b-IFIs were observed in patients with prolonged neutropenia and active leukemia.

References

11